| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |